---
$id: https://graph.org.ai/products/commodity/51152017
$type: Product
source: UNSPSC
code: "51152017"
title: "Baclofen"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Baclofen

**UNSPSC Code**: 51152017
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C10H12ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H789N3FKE8, chemically known as hydrocinnamic acid, beta-(aminomethyl)-p-chloro- but generally known as baclofen, which bears US NIH Compound Identifier 2284. European Medicines Agency schedules Baclofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05667MIG. The term BACLOFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules baclofen in its Anatomical Therapeutic Chemical (ATC) Classification. BACLOFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule baclofen under HS 29224995 and SITC 51465. As of Q4 2014, BACLOFEN remains the US FDA Preferred Term for this commodity. Baclofen bears US NLM identifiers UMLS ID C0004609 and NCI Concept Code C28858. SMILES: C1=CC(=CC=C1C(CC(=O)O)CN)CL.

